The influence of disease-modifying therapy on hidden disability burden in people with newly diagnosed relapsing-remitting multiple sclerosis
Stella A. Glasmacher, Patrick K. A. Kearns, Zackary Hassan, Peter Connick, Simone C. Tauber, Kathrin Reetz, Peter Foley, Siddharthan Chandran
Topics & Concepts
Relapsing remittingMedicineMultiple sclerosisDiseaseBurden of diseaseDisease burdenPsychiatryInternal medicineMultiple Sclerosis Research StudiesAmyotrophic Lateral Sclerosis ResearchLong-Term Effects of COVID-19